Needleless connector and access port disinfection cleaner and antimicrobial protection cap

ABSTRACT

A protective cap having a first cap and a second cap that are removably coupled together for use in short-term and long-term antimicrobial treatment of needleless connectors and access ports of an infusion system. The instant invention further provides a protective cap having a first cap and a second cap that each coupled to a different surface of a component of an infusion system, such as a syringe. The instant invention further provides a strip containing a plurality of disposable protective caps.

RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No.13/766,540 filed Feb. 13, 2013, and titled NEEDLELESS CONNECTOR ANDACCESS PORT DISINFECTION CLEANER AND ANTIMICROBIAL PROTECTION CAP, andis incorporated herein by reference.

BACKGROUND OF THE INVENTION

Catheter-related bloodstream infections are caused by bacteria/fungi inpatients with intravascular catheters. These infections are an importantcause of illness and excess medical costs, as approximately 80,000catheter-related bloodstream infections occur in U.S. intensive careunits each year. In addition to the monetary costs, these infections areassociated with anywhere from 2,400 to 20,000 deaths per year.

Guidelines from the Centers for Disease Control and Prevention describevarious ways to limit catheter-related bloodstream infections inhospital, outpatient and home care settings. The guidelines addressissues such as hand hygiene, catheter site care and admixturepreparation. Despite these guidelines, catheter-related bloodstreaminfections continue to plague our healthcare system.

Protective caps incorporating various disinfectants and/or antimicrobialagents are one approach that has been implemented to prevent theseinfections at needleless connection points. While these caps areeffective for long-term protection against pathogens, long-term exposureto the antimicrobial agent or disinfectant can cause damage to theneedleless connection or access point of a medical device. In someinstances, the antimicrobial agent is suspended in an alcohol solvent.The alcohol solvent used in the protective cap has been shown to causedevice failure in many connector type devices. To prevent this damage,some protective caps are designed to permit the alcohol-base toevaporate from the protective cap. However, once the alcohol solvent hasevaporated, the effectiveness of the protective cap is diminished.

Therefore, there is a need for an effective and inexpensive way toreduce the number of catheter-related infections for needlelessconnectors and access ports. Such methods and systems are disclosedherein.

BRIEF SUMMARY OF THE INVENTION

In some implementations, a protective cap is provided for antisepticallymaintaining a patient fluid line access valve (i.e. access valve) or aneedleless connector. In some instances, a protective cap is providedhaving a first cap that is removable coupled to a second cap, whereinthe first cap has a first opening comprising a cavity in which isdisposed a first pad. The first cap further comprises a coupling featurefor receiving the second cap.

The second cap further includes a second opening having a cavity inwhich is disposed a second pad. The second opening further includes acompatible coupling feature whereby to receive or otherwise interconnectwith the coupling feature of the first cap. The first and second capseach contain an antimicrobial composition that is configured to clean aneedleless connector and/or an access port of an infusion system, suchas an intravenous catheter assembly or intravenous tubing. In someimplementations, the first opening of the first cap is temporarilysealed with a lid to prevent contamination and evaporation of theantimicrobial composition stored within the first pad. Further, in someinstances the connection between the coupling features to the first andsecond caps prevents contamination of the second pad prior to use.

Some implementations of the present invention further include aprotective cap system having a first and second cap that areindependently coupled to different surfaces of an infusion device, suchas a syringe. The first and second caps are independently removed fromthe syringe and applied to various surfaces to achieve short-term andlong-term antimicrobial protection to various components of an infusionsystem.

Some implementations of the present invention further include a striphaving a plurality of holes or openings for temporarily storing andorganizing a plurality of protective caps. The protective caps comprisea first cap and a second cap, wherein each cap is configured to provideshort-term and/or long-term antimicrobial protection to variouscomponents of an infusion system. In some instances, the openings of thefirst and second caps are sealed to a strip, rather than being insertedthrough an opening or hole.

BRIEF DESCRIPTION OF THE SEVERAL VIEWS OF THE DRAWINGS

In order that the manner in which the above-recited and other featuresand advantages of the invention are obtained will be readily understood,a more particular description of the invention briefly described abovewill be rendered by reference to specific embodiments thereof which areillustrated in the appended drawings. These drawings depict only typicalembodiments of the invention and are not therefore to be considered tolimit the scope of the invention.

FIG. 1, shown in parts A and B, shows a protective cap device having afirst cap threadedly coupled to a second cap in accordance with arepresentative embodiment of the present invention.

FIG. 2, shown in parts A and B, shows a protective cap device having afirst cap unthreaded from a second cap in accordance in accordance witha representative embodiment of the present invention.

FIG. 3 shows a cross-section view of a protective cap device having afirst cap mechanically coupled to a second cap in accordance with arepresentative embodiment of the present invention.

FIG. 4, shown in parts A and B, shows a needleless device fitted with aprotective cap device having a first cap coupled to a nozzle of theneedleless device, and a second cap stored on plunger of the needlelessdevice in accordance with a representative embodiment of the presentinvention.

FIG. 5, shown in parts A and B, shows perspective and detailed views ofa plurality of protective caps arranged on a strip for convenientlyproviding multiple caps for use in protecting a needleless connector inaccordance with a representative embodiment of the present invention.

DETAILED DESCRIPTION OF THE INVENTION

The presently preferred embodiment of the present invention will be bestunderstood by reference to the drawings, wherein like reference numbersindicate identical or functionally similar elements. It will be readilyunderstood that the components of the present invention, as generallydescribed and illustrated in the figures herein, could be arranged anddesigned in a wide variety of different configurations. Thus, thefollowing more detailed description, as represented in the figures, isnot intended to limit the scope of the invention as claimed, but ismerely representative of presently preferred embodiments of theinvention.

Referring now to FIGS. 1A and 1B, a protective cap 10 is shown.Generally, protective cap 10 comprises a first cap 20 that is coupled toa second cap 40. Each cap 20 and 40 is configured to receive orotherwise couple to a needleless connector or access port of a componentof an infusion system. In some instances, first cap 20 is configured toreceive a needleless connector without being attached to the needlelessconnector long-term. For example, first cap 20 may be used to quicklyclean a needleless connector just prior to the needleless connectorbeing coupled to a second medical device. In other instances, second cap40 is configured to be attached to a needleless connector for long-termprotection. For example, in some embodiments second cap 40 comprises aset of threads or other feature for securely receiving and retaining aportion of a needleless connector.

In some embodiments, first and second caps 20 and 40 are separated andapplied to a needleless connector or access port to prevent pathogensfrom colonizing thereon. Further, in some embodiments first cap 20 istemporarily applied to a needleless connector or access port to kill anypathogens present thereon. The first cap 20 is then removed from theneedleless connector or access port and the port is connected to, oraccessed with a component of an infusion system. Upon removal of thecomponent of the infusion system, first cap 20 is removed from secondcap 40, and second cap 40 is fixedly coupled to the needleless connectoror access port for long-term protection.

Protective cap 10 may comprise any material that is compatible for usein an infusion system. For example, in some embodiments protective capcomprises any of a number of types of plastic materials such aspolycarbonate, polypropylene, polyethylene, glycol-modified polyethyleneterephthalate, acrylonitrile butadiene styrene or any other moldableplastic material used in medical devices.

In some embodiments, first cap 20 and second cap 40 are selectivelycoupled to form protective cap 10. For example, in some embodimentsfirst cap 20 comprises a set of threads 22 that is configured tointerlock with a set of mating threads 42 on second cap 40. In someinstances, first cap 20 comprises a post 24 that supports threads 22 ina configuration that permits an opening 46 of second cap 40 to receivepost 24 and threads 22. In some instances, mating threads 42 comprises aset of female threads that are formed into an inner surface 44 of secondopening 46. Other embodiments include a cavity (not shown) on first cap20 having internal threads and a width sufficient to receive externalthreads (not shown) located on an outer surface of second cap 40.

First cap 20 further comprises a first opening 28 having a first pad 30disposed therein. First pad 30 generally comprises an absorbentmaterial, such as a sponge or other non-woven material. In someinstances, first pad 30 comprises an absorbent, woven material. Firstpad 30 may be secured into first opening by mechanical interference.Alternatively, first pad 30 may be secured into first opening 28 via abiocompatible adhesive.

In some instances, first pad 30 further comprises a central, cylindricalcutout 32 that is not directly, physically coupled to the inner surfaceof opening 28. Rather, cutout 32 may be collapsed or compressed toprovide a central hole or cavity within first pad 30. For example,cutout 32 may be compressed by inserting a device into opening 28, suchas needleless connector or access port. In this way, a tip and sides ofthe inserted device may be simultaneously contacted by first pad 30without disrupting the bond between first pad 30 and the inner surfaceof second opening 28.

Second cap 40 further comprises a second pad 48 that is fixedly seatedinto second opening 46. Second pad 48 generally comprises a woven ornon-woven absorbent material, such as a sponge. In some embodiments,second pad 48 is positioned within second opening 46 so that second pad48 does not contact post 24 when first cap 20 is threadedly coupled tosecond cap 40. In other embodiments, second pad 48 is compressed withinsecond opening 46 by post 24 when first cap 20 is threadedly coupled tosecond cap 40. Upon separation of first and second caps 20 and 40,second pad 48 is uncompressed and expands such that second pad 48contacts and/or overlaps threads 42. This feature may be desirable fortreating threads 42 with an antimicrobial composition stored in secondpad 48.

First and second pads 30 and 48 may comprise an antimicrobialcomposition that is effective in preventing growth and colonization ofpathogens, and that is safe for use in an infusion system. Anantimicrobial composition in accordance with the present inventiongenerally comprises an antimicrobial or biocidal agent effective againstvarious forms and strains of bacteria which may cause infection within apatient. The terms “biocidal agent” “antimicrobial agent” or “biocide,”as used herein refer to an agent that destroys, inhibits and/or preventsthe propagation, growth, colonization and multiplication of unwantedorganisms. The term “organism” includes, but is not limited to,microorganisms, bacteria, undulating bacteria, spirochetes, spores,spore-forming organisms, gram-negative organisms, gram-positiveorganisms, yeasts, fungi, molds, viruses, aerobic organisms, anaerobicorganisms and mycobacteria.

Specific examples of such organisms include the fungi Aspergillus niger,Aspergillus flavus, Rhizopus nigricans, Cladosprorium herbarium,Epidermophyton floccosum, Trichophyton mentagrophytes, Histoplasmacapsulatum, and the like; bacteria such as Pseudomanas aeruginosa,Escherichia coli, Proteus vulgaris, Staphylococcus aureus,Staphylococcus epidermis, Streptococcus faecalis, Klebsiella,Enterobacter aerogenes, Proteus mirabilis, other gram-negative bacteriaand other gram-positive bacteria, mycobactin and the like; and yeastsuch as Saccharomcyces cerevisiae, Candida albicans, and the like.Additionally, spores of microorganisms, viruses and the like areorganisms within the scope of the present invention.

Antimicrobial or biocide agents suitable for use in the presentinvention include, but are not limited to phenol, quaternary ammonium,guanidine, taurolidine, parachlorometaxylenol, silver sulfadiazine,silver oxide, silver nitrate, pyridinium, benzalkonium chloride,cetrimide, benethonium chloride, cetylpyridinium chloride, dequaliniumacetate, dequalinium chloride, and chloroxylenol. Further, in someembodiments a biocide agent comprises a microbial agent selected fromchlorhexidine base, chlorhexidine gluconate, chlorhexidine acetate,chlorhexidine hydrochloride, chlorhexidine dihydrochloride,dibromopropamidine, halogenated diphenylalkanes, carbanilide,salicylanilide, tetrachlorosalicylanilide, trichlorocarbanilide, andmixtures thereof. Still further, in some embodiments a biocide agentcomprises a microbial agent selected from chlorhexidine dihydrochloride,chlorhexidine gluconate, chlorhexidine acetate, chlorhexidine diacetate,triclosan, chloroxylenol, dequalinium chloride, benzethonium chloride,benzalkonium chloride, and combinations thereof.

In some embodiments first or second pads 30 and 48 comprise a liquidantimicrobial composition. In other embodiments, first or second pads 30and 48 comprise a dehydrated antimicrobial composition, wherein thedehydrated antimicrobial composition is activated upon rehydration witha fluid, such as water, alcohol, blood, or another liquid common toinfusion therapies. In some instances, lid 50 provides a fluid tightseal for first opening 28, thereby preventing premature evaporation ofan antimicrobial composition stored in first pad 30. Further still, insome instances interlocked threads 42 and 22 provide a fluid tight sealfor second opening 46, thereby preventing premature evaporation of anantimicrobial composition stored in second pad 48.

In some embodiments, first pad 30 comprises a liquid antimicrobialcomposition, wherein lid 50 prevents premature evaporation of theantimicrobial agent prior to use. In other embodiments, second pad 48comprises a dehydrated antimicrobial composition, wherein the dehydratedantimicrobial composition is activated upon rehydration with a fluid,such as water, alcohol, blood, or another liquid common to infusiontherapies. In some instances, the dehydrated state of second pad 48prevents long-term exposure of the needleless connector to a liquid,alcohol-based antimicrobial composition. Contact between a dehydratedcomposition within second pad 48 and the surface of the needlelessconnector provides antimicrobial protection without causing damagethereto. As such, damage to the needleless connector caused by a liquid,alcohol-based antimicrobial composition is prevented. Further, thedehydrated state of the second pad 48 wicks or removes fluids from theneedleless connector, thereby preventing damage and/or colonization ofmicrobes on the needleless connector. Once wicked into second pad 48,the dehydrated antimicrobial agent is activated and microbes within thefluid are neutralized.

In some instances, first and second pads 30 and 48 each comprise anidentical antimicrobial composition. In other instances, first pad 30comprises a first antimicrobial composition, and second pad 48 comprisesa second antimicrobial composition, wherein the first and secondantimicrobial compositions are different. Thus, first cap 20 may be usedto provide a first type of disinfection, and second cap 40 may be usedto provide a second type of disinfection.

Prior to use, first and second caps 20 and 40 are threadedly coupledtogether and first opening 28 is sealed with a lid 50, such as a pieceof foil, a thin polymer membrane, a foil-backed piece of paper, or apolymer-backed piece of paper. To use protective cap 10, a user mayremove lid 50 to expose first pad 30 seated in first opening 28. A usermay insert an access valve or a needleless connector into first opening28 and into contact with first pad 30. The access valve or needlelessconnector is treated with the antimicrobial composition as the surfacesare contacted with first pad 30.

Once the access valve or needleless connector is cleaned, it may beconnected to another component of an infusion system. Upon disconnectingthe access valve or needleless connector, second cap 40 is removed orunthreaded from first cap 20, as shown in FIGS. 2A and 2B. Second cap 40is attached to the disconnected valve or connector to provideantimicrobial protection thereto during long-term storage.

For example, in some embodiments the access valve or needlelessconnector comprises a set of threads that are compatibly received by theset of mating threads 42 located on inner surface 44 of second cap 40.When second cap 40 is threadedly connected to the valve or connector,second pad 48 contacts the valve or connector to provide antimicrobialcleaning and protection. The threaded connection between second cap 40and the access valve or connector further prevents exposure of theneedleless connector to microbes or other contaminants. In someinstances, the threaded connection prevents exposure to fluids which mayleak from the valve or connector.

Referring now to FIG. 3, first and second caps 20 and 40 may beselectively coupled by any means. For example, in some embodiments post24 of first cap 20 comprises an annular ring 26 that snaps into anannular groove 45 that is formed on inner surface 44 of second cap 40.The interaction between ring 26 and groove 45 provide a mechanicalconnection that may be separated by pulling apart the first and secondcaps 20 and 40. Ring 26 and groove 45 further provide a fluid tightseal, thereby preventing evaporation of an antimicrobial compositionstored in second pad 48.

In some instances, an access valve or needleless connection furthercomprises an annular ring that is compatibly received by annular groove45 when second cap 40 is placed thereon. In other embodiments, secondcap 40 is retained by the access valve or needleless connection viamechanical interference or friction fit.

In some embodiments, a protective cap comprising a set of individualcaps may be configured for attachment to a pre-filled syringe 100, asshown in FIGS. 4A and 4B. In some instances it is desirable to provide asyringe 100 that is pre-filled with a desired liquid 102. In theseinstances, it is further desirable that the liquid 102 and theneedleless connector or nozzle 104 remain free from pathogens before andduring use.

Accordingly, in some embodiments a first cap 120 is provided having areceptacle 122 for receiving nozzle 104 of syringe 100. Prior to cappingnozzle 104 with receptacle 122 of first cap 120, receptacle 122 issterilized. This prevents contamination of nozzle 104 and fluid 102, asmay be desired. Sterilization of receptacle 122 may be achieved by anyknown method in the art.

First cap 120 further comprises a first opening 128 in which is seated afirst pad 130. First pad 130 may comprises an antimicrobial compositionthat is configured to clean an access port (not shown) intended toreceive nozzle 104 of syringe 100. First cap 120 may further include alid 150 to protect first pad 130 and prevent evaporation of theantimicrobial composition prior to use.

The protective cap may further include a second cap 140 that isremovable coupled to a portion of syringe 100. For example, in someembodiments cap 140 is coupled to the plunger 106 of syringe 100.Plunger 106 may comprise a circular groove 107 that is configured toreceive and temporarily store second cap 140. In some embodiments,second cap 140 is threadedly secured to plunger 106. In otherembodiments, second cap 140 is coupled to plunger 106 via a frictionfit.

The connection between second cap 140 and syringe 100 preventsevaporation and/or contamination of an antimicrobial agent stored insecond cap 140. For example, in some instances second cap 140 comprisesa second pad 148 containing an antimicrobial composition. The connectionbetween second cap 140 and syringe 100 provides a fluid tight seal forsecond pad 148. The connection between second cap 140 and syringe 100further provides convenient placement of second cap 140 for access by auser of the syringe.

For example, in some embodiments a user of syringe 100 first removes lid150 from first cap 120 to expose first pad 130. First pad 130 is thenused to clean an access port of an infusion system. The access port isclean by inserting the access portion within second opening 128 tocontact first pad 130. First cap 120 is then removed from nozzle 104.Nozzle 104 is then connected to the access port.

In some instances, a desired volume of fluid 102 is injected into theinfusion system via an access port. Where the desired volume comprisesthe entire contents of syringe 100, second cap 140 may be removed fromplunger 106 following injection of liquid 102, and connected to theaccess port to prevent subsequent contamination thereof. Where thedesired volume comprises only a portion of the contents of syringe 100,and where it is desirable to use the remaining contents of syringe 100at a later time, second cap 140 may be removed from plunger 106 andcoupled to nozzle 104 to prevent subsequent contamination thereof.Second cap 140 further prevents contamination of the remaining fluid102. At the time in which it is desirable to inject the remaining fluid102 into the access port, second cap 140 is removed from nozzle 104 andis used to clean the access port. The clean nozzle 104 is then insertedinto the clean access port, and the remaining fluid is injected withoutintroducing microbes into the infusion system. In some embodiments,second cap 140 is then coupled to the access port to provide long-termantimicrobial protection.

Referring now to FIGS. 5A and 5B, a plurality of protective caps 10 isprovided on a strip 200 that is configured to be removable coupled to amedical device, such as an IV stand 210. This configuration may bedesirable for situations where a needless connector 220 may requirerepeated cleanings over a period of use. In some embodiments, strip 200comprises a plurality of holes or openings 202 through which each cap isfitted. In some instances, each cap comprises a first cap 20 and asecond cap 40, wherein strip 200 is inserted between the two caps.

In some instances, cap 10 is removed from strip 200 by separating firstcap 20 from second cap 40. In other instances, cap 10 is removed fromstrip 200 by stretching or biasing opening 202 via pushing or pullingcap 10. First and second caps 20 and 40 may be used to clean needlelessconnector 220, in accordance with the teachings above. Upon subsequentcleanings, the first and second caps of a first protective cap arediscarded and an additional protective cap is removed from strip 200 andused. An enlarged opening 206 may be provided to assist in couplingstrip 200 to a desired medical device 210. In some embodiments, strip200 is temporarily secured to a medical device via an adhesive strip orother suitable means.

The present invention may be embodied in other specific forms withoutdeparting from its structures, methods, or other essentialcharacteristics as broadly described herein and claimed hereinafter. Thedescribed embodiments are to be considered in all respects only asillustrative, and not restrictive. The scope of the invention is,therefore, indicated by the appended claims, rather than by theforegoing description. All changes that come within the meaning andrange of equivalency of the claims are to be embraced within theirscope.

The invention claimed is:
 1. A device for antiseptically maintaining apatient fluid line access valve, the device comprising: a first capcomprising a distal end and a proximal end, wherein the distal end ofthe first cap comprises a first opening having a first pad disposedtherein, and the proximal end comprises a post having a solidcross-section and extending outwardly from the proximal end, the solidcross-section comprising a coupling feature; and a second cap comprisinga distal end and a proximal end, wherein the distal end of the secondcap comprises a second receptacle having a second pad disposed therein,wherein the second receptacle comprises a compatible coupling feature influid communication with the second pad and configured to receive thecoupling feature on the solid cross-section of the post of the first capto form a fluid tight seal.
 2. The device of claim 1, wherein the firstcap comprises a removable lid that covers the first opening.
 3. Thedevice of claim 2, wherein the removable lid comprises at least one of afoil lidding material and a polymer lidding material.
 4. The device ofclaim 1, wherein the first opening is configured to receive an accessportion of a patient fluid line access valve.
 5. The device of claim 4,wherein the first opening includes a set of threads that is configuredto receive a compatible set of threads on the access portion of thepatient fluid line access valve.
 6. The device of claim 1, furthercomprising a syringe having a first end comprising a spout and a secondend comprising a base of a plunger, wherein the base of the plungerincludes a circular groove that receives the distal end of the secondcap to thereby couple the second cap to the plunger.
 7. The device ofclaim 1, further comprising a first antimicrobial solution applied tothe first pad and a second antimicrobial solution applied to the secondpad.
 8. The device of claim 7, wherein the first antimicrobial solutioncomprises a wet solution selected from at least one of a firstantimicrobial agent from approximately 0.01% to approximately 10.0%(v/v), and an alcohol from approximately 50% to approximately 99.99%(v/v), wherein the second antimicrobial solution comprises a dryantimicrobial coating comprising a second antimicrobial agent.
 9. Thedevice of claim 8, wherein the first and second antimicrobial agents areselected from the group consisting of chlorhexidine acetate,chlorhexidine gluconate, PVP-I, Triclosan, PCMX, BEC, BAC, antibiotic,Octinidine, and suitable salts thereof.
 10. The device of claim 7,wherein the first antimicrobial solution comprises a wet, water-basedsolution, comprising: a first antimicrobial agent from approximately0.01% to approximately 10.0% (v/v); an alcohol solvent fromapproximately 1% to approximately 10% (v/v); and water fromapproximately 90% to approximately 99% (v/v); and wherein the secondantimicrobial solution comprises a dry antimicrobial coating comprisinga second antimicrobial agent.
 11. The device of claim 10, wherein thefirst and second antimicrobial agents are selected from the groupconsisting of chlorhexidine acetate, chlorhexidine gluconate, PVP-I,Triclosan, PCMX, BEC, BAC, antibiotic, Octinidine, and suitable saltsthereof.
 12. The device of claim 1, wherein the first pad comprises acentral, cylindrical cutout configured to compress to provide a centralcavity in response to a device being inserted into the first opening,wherein the central cylindrical cutout does not provide the centralcavity when the first pad is uncompressed.